Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: Comparison between oral ferrous bisglycinate chelate and ferrous sulfate

Biomedicine and Pharmacotherapy

Volumn 66, Issue 6, 2012, Pages 414-418

  Ferrari, Paola ^a   Nicolini, Andrea ^a   Manca, Maria Laura ^a   Rossi, Giuseppe ^b   Anselmi, Loretta ^a   Conte, Massimo ^a   Carpi, Angelo ^a   Bonino, Ferruccio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CNR   (Italy)

Author keywords

Cancer; Ferrous bisglycinate chelate; Iron deficiency anemia

Indexed keywords

FERRITIN; FERROUS BISGLYCINATE CHELATE; FERROUS SULFATE; HEMOGLOBIN; IRON CHELATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DYSPEPSIA; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY ANEMIA; MALE; NAUSEA; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; ANEMIA, IRON-DEFICIENCY; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DIETARY SUPPLEMENTS; FEMALE; FERRITINS; FERROUS COMPOUNDS; FOLLOW-UP STUDIES; GLYCINE; HEMATINICS; HEMOGLOBINS; HUMANS; IRON CHELATING AGENTS; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 84866157598     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2012.06.003     Document Type: Article

References (33)

1. Ludwig H., Van Belle S., Barrett-Lee P., Birgegård G., Bokemeyer C., Gascón P., et al. The European Cancer Anemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anemia in cancer patients. Eur J Cancer 2004, 40:2293-2306.
2. Caro J.J., Salas M., Ward A., Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001, 91:2214-2221.
3. Cella D., Kallich J., McDermott A., et al. The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trials. Ann Oncol 2004, 15:979-986.
4. Denny S.D., Kuchibhatla M.N., Cohen H.J. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med 2006, 119:327-334.
5. Glaspy J. Disorders of blood cell production in clinical oncology. Clinical Oncology 2008, 677-692. Churchill Livingstone-Elsevier, Philadelphia (PA), Chap. 45. 4th ed. M.D. Abeloff, J.O. Armitage, J.E. Niederhuber, M.B. Kastan, W.G. McKenna (Eds.).
6. Bayraktar U.D., Bayraktar S. Treatment of iron deficiency anemia associated with gastrointestinal tract diseases. World J Gastroenterol 2010, 16:2720-2725.
7. Goddard A.F., James M.W., McIntyre A.S., Scott B.B. Guidelines for the management of iron deficiency anemia. Gut 2011, 60:1309-1316. British Society of Gastroenterology.
8. Hallberg L., Ryttinger L., Sölvell L. Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form. Acta Med Scand Suppl 1966, 459:3-10.
9. Rockey D.C. Treatment of iron deficiency. Gastroenterology 2006, 130:1367-1368.
10. Brock C., Curry H., Hanna C., Knipfer M., Taylor L. Adverse effects of iron supplementation: a comparative trial of a wax-matrix iron preparation and conventional ferrous sulfate tablets. Clin Ther 1985, 7:568-573.
11. Jacobs P., Fransman D., Coghlan P. Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron-deficient blood donors. J Clin Apher 1993, 8:89-95.
12. Jeppsen R.B., Borzelleca J.F. Safety evaluation of ferrous bisglycinate chelate. Food Chem Toxicol 1999, 37:723-731.
13. Coplin M., Schuette S., Leichtmann G., Lashner B. Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfate. Clin Ther 1991, 13:606-612.
14. Pineda O., Ashmead H.D. Effectiveness of treatment of iron-deficiency anemia in infants and young children with ferrous bis-glycinate chelate. Nutrition 2001, 17:381-384.
15. Layrisse M., García-Casal M.N., Solano L., Barón M.A., Arguello F., Llovera D., et al. Iron bioavailability in humans from breakfasts enriched with iron bis-glycine chelate, phytates and polyphenols. J Nutr 2000, 130:2195-2199.
16. Iost C., Name J.J., Jeppsen R.B., Ashmead H.D. Repleting hemoglobin in iron deficiency anemia in young children through liquid milk fortification with bioavailable iron amino acid chelate. J Am Coll Nutr 1998, 17:187-194.
17. Mimura E.C., Breganó J.W., Dichi J.B., Gregório E.P., Dichi I. Comparison of ferrous sulfate and ferrous glycinate chelate for the treatment of iron deficiency anemia in gastrectomized patients. Nutrition 2008, 24:663-668.
18. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5(7.pdf.
19. http://www.jnp.com/.
20. http://www.nccn.org/clinical.asp.
21. Beutler E. Disorders of iron metabolism. Williams hematology 2006, 511-533. Mc Graw-Hill Medical, New York. 7th ed. M.A. Lichtmen, B.J. Williams, E. Beutler, A. et (Eds.).
22. Van Wyck D.B., Roppolo M., Martinez C.O., Mazey R.M., McMurray S. For the United States Iron Sucrose (Venofer) Clinical Trials Group. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney Int 2005, 68:2846-2856.
23. Qunibi W.Y., Martinez C., Smith M., Benjamin J., Mangione A., Roger S.D. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients. Nephrol Dial Transplant 2011, 26:1599-1607.
24. Zhou S.J., Gibson R.A., Crowther C.A., Makrides M. Should we lower the dose of iron when treating anemia in pregnancy? A randomized dose-response trial. Eur J Clin Nutr 2009, 63:183-190.
25. Rimon E., Kagansky N., Kagansky M., Mechnick L., Mashiah T., Namir M., et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 2005, 118:1142-1147.
26. Pasricha S.R., Flecknoe-Brown S.C., Allen K.J., Gibson P.R., McMahon L.P., Olynyk J.K., et al. Diagnosis and management of iron deficiency anemia: a clinical update. Med J Aust 2010, 193:525-532.
27. Makrides M., Crowther C.A., Gibson R.A., Gibson R.S., Skeaff C.M. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am J Clin Nutr 2003, 78:145-153.
28. Pineda O., Ashmead H.D., Perez J.M., Lexus C.P. Effectiveness of iron amino acid chelate on the treatment of iron deficiency anemia in adolescents. J Appl Nutr 1994, 46:2-13.
29. Hunt G.C., Faigel D.O. Endoscopic evaluation of patients with partial gastrectomy and iron deficiency. Dig Dis Sci 2002, 47:641-644.
30. Ajmera A.V., Shastri G.S., Gajera M.J., Judge T.A. Suboptimal response to ferrous sulfate in iron-deficient patients taking omeprazole. Am J Ther 2012, 19:185-189.
31. Ito T., Jensen R.T. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. Curr Gastroenterol Rep 2010, 12:448-457.
32. Jeong O., Park Y.K., Ryu S.Y. Prevalence, severity, and evolution of postsurgical anemia after gastrectomy, and clinicopathological factors affecting its recovery. J Korean Surg Soc 2012, 82:79-86.
33. Baker A., Wooten L.A., Malloy M. Nutritional considerations after gastrectomy and esophagectomy for malignancy. Curr Treat Options Oncol 2011, 12:85-95.